Bio-Techne is set to report its Q3 earnings with expectations of flat revenue and a slight EPS decline, against a backdrop of broader biotech funding challenges. Industry experts note early-stage ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bio-Techne (NASDAQ:TECH) and the best and ...

Bio-Techne reported a 2% revenue decline for its third fiscal quarter and a 34.2% adjusted operating income margin, down 70 basis points. Revenue from biotech customers declined in the high single ...